/

West Pharmaceutical Services, Inc.

WST US

WST USWest Pharmaceutical Services, Inc.

United States Composite

365.70

USD

+2.44

(+0.67%)

7.88EPS Dil.

45.77P/E

26.88BMarket Cap

0.21%Div. Yield

Next Earnings

April 25

Ex-Dividend Date

April 23

Dividend Date

May 1

Held by Insiders

0.56%

Held by Institutions

95.89%

Short % of Float

1.64%

YTD Yield

-2.49%

3Y Yield

9.71%

5Y Yield

195.82%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

152

LT Borrowings

206

152

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

28,265

27,766

25,881

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

1,874

1,972

1,936

Cash, Cash Equivalents & STI

796

899

854

Accounts Receivable, Net

534

519

512

Inventories

449

432

435

Total Current Liabilities

512

534

672

Payables & Accruals

330

325

424

ST Debt

152

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

8.34%

11.98%

2.18%

Net Income, GAAP

22.19%

28.19%

1.19%

Free Cash Flow

29.36%

18.57%

-5.47%

Total Cash Common Dividend

7.78%

6.30%

5.56%

Total Equity

12.41%

15.75%

7.30%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

671

724

707

731

2,832

2022

720

771

687

709

2,887

2023

717

754

747

732

2,950

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

2.05

2.53

2.37

1.95

8.90

2022

2.34

2.53

1.62

1.38

7.88

2023

1.88

2.09

2.17

1.85

7.99

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

0.17

0.18

0.69

2022

0.18

0.19

0.73

2023

0.19

0.20

0.77

Company Description

Full Time Employees: 10,600
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 530 Herman O. West Drive Exton PA United States 19341-1147
IPO Date: Mar 17, 1980
CIK: 0000105770
Website: www.westpharma.com
Business: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Company News

Yahoo
3 days ago
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
Yahoo
3 days ago
West to Participate in Upcoming Investor Conference
Yahoo
5 days ago
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Yahoo
6 days ago
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight
Yahoo
7 days ago
West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
Yahoo
7 days ago
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Yahoo
7 days ago
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Zacks
7 days ago
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Yahoo
8 days ago
West Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales Decline
Reuters
8 days ago
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
Zacks
8 days ago
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
Marketwatch
8 days ago
West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease
Yahoo
8 days ago
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
Zacks
8 days ago
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Zacks
8 days ago
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Zacks
11 days ago
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?

Company Description

Full Time Employees: 10,600
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 530 Herman O. West Drive Exton PA United States 19341-1147
IPO Date: Mar 17, 1980
CIK: 0000105770
Website: www.westpharma.com
Business: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Company News

Yahoo
3 days ago
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
Yahoo
3 days ago
West to Participate in Upcoming Investor Conference
Yahoo
5 days ago
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Yahoo
6 days ago
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight
Yahoo
7 days ago
West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
Yahoo
7 days ago
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Yahoo
7 days ago
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Zacks
7 days ago
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Yahoo
8 days ago
West Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales Decline
Reuters
8 days ago
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
Zacks
8 days ago
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
Marketwatch
8 days ago
West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease
Yahoo
8 days ago
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
Zacks
8 days ago
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Yahoo
8 days ago
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Zacks
8 days ago
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Zacks
11 days ago
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?